Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides
Chemical Reviews · 2023
DOI: 10.1021/acs.chemrev.3c00456 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Reviews, 2023. Verfasst von Katherine A Morgan und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Melbourne 3010, Australia. Hauptthemen laut MEDLINE: Copper Radioisotopes, Nuclear Medicine. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 262 Literaturangaben. Gefördert von: National Health and Medical Research Council, Australian Cancer Research Foundation, Australian Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Melbourne 3010, Australia.
ORCID-Profile: Paul S Donnelly
Förderung
- National Health and Medical Research Council
- Australian Cancer Research Foundation
- Australian Research Council
- Cancer Council Victoria
Zitieren
APA
Morgan, K. A., Rudd, S. E., Noor, A., & Donnelly, P. S. (2023). Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides. Chemical Reviews. https://doi.org/10.1021/acs.chemrev.3c00456
Vancouver
Morgan KA, Rudd SE, Noor A, Donnelly PS. Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides. Chemical Reviews. 2023. doi:10.1021/acs.chemrev.3c00456
BibTeX
@article{Morgan2023,
author = {Morgan, Katherine A and Rudd, Stacey E and Noor, Asif and Donnelly, Paul S},
title = {Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides},
journal = {Chemical Reviews},
year = {2023},
doi = {10.1021/acs.chemrev.3c00456}
}
EUVIMED